Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, Paulien Kaptein, Lea J. Albrecht, Batool Shannan, Jan C. Brase, Daniel Gusenleitner, Teresa Amaral, Nina Wyss, Jochen Utikal, Lukas Flatz, Florian Rambow, Hans Christian Reinhardt, Jenny Dick, Daniel R. Engel, Susanne Horn, Selma Ugurel, Wiebke Sondermann, Elisabeth Livingstone, Antje Sucker, Annette Paschen, Fang Zhao, Jan M. Placke, Jasmin M. Klose, Wolfgang P. Fendler, Daniela S. Thommen, Iris Helfrich, Dirk Schadendorf, Alexander Roesch

Open source

DOI: 10.1038/s43018-023-00610-2
Published: 2023-07-31
Container: Nature Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-023-00610-2,
  title = {Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma},
  author = {Renáta Váraljai and Lisa Zimmer and Yahya Al-Matary and Paulien Kaptein and Lea J. Albrecht and Batool Shannan and Jan C. Brase and Daniel Gusenleitner and Teresa Amaral and Nina Wyss and Jochen Utikal and Lukas Flatz and Florian Rambow and Hans Christian Reinhardt and Jenny Dick and Daniel R. Engel and Susanne Horn and Selma Ugurel and Wiebke Sondermann and Elisabeth Livingstone and Antje Sucker and Annette Paschen and Fang Zhao and Jan M. Placke and Jasmin M. Klose and Wolfgang P. Fendler and Daniela S. Thommen and Iris Helfrich and Dirk Schadendorf and Alexander Roesch},
  year = {2023},
  journal = {Nature Cancer},
  doi = {10.1038/s43018-023-00610-2},
  url = {https://doi.org/10.1038/s43018-023-00610-2}
}

RIS

TY  - JOUR
TI  - Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
AU  - Renáta Váraljai
AU  - Lisa Zimmer
AU  - Yahya Al-Matary
AU  - Paulien Kaptein
AU  - Lea J. Albrecht
AU  - Batool Shannan
AU  - Jan C. Brase
AU  - Daniel Gusenleitner
AU  - Teresa Amaral
AU  - Nina Wyss
AU  - Jochen Utikal
AU  - Lukas Flatz
AU  - Florian Rambow
AU  - Hans Christian Reinhardt
AU  - Jenny Dick
AU  - Daniel R. Engel
AU  - Susanne Horn
AU  - Selma Ugurel
AU  - Wiebke Sondermann
AU  - Elisabeth Livingstone
AU  - Antje Sucker
AU  - Annette Paschen
AU  - Fang Zhao
AU  - Jan M. Placke
AU  - Jasmin M. Klose
AU  - Wolfgang P. Fendler
AU  - Daniela S. Thommen
AU  - Iris Helfrich
AU  - Dirk Schadendorf
AU  - Alexander Roesch
PY  - 2023
JO  - Nature Cancer
DO  - 10.1038/s43018-023-00610-2
UR  - https://doi.org/10.1038/s43018-023-00610-2
ER  -

APA

Váraljai, R., Zimmer, L., Al-Matary, Y., Kaptein, P., Albrecht, L. J., Shannan, B., Brase, J. C., Gusenleitner, D., Amaral, T., Wyss, N., Utikal, J., Flatz, L., Rambow, F., Reinhardt, H. C., Dick, J., Engel, D. R., Horn, S., Ugurel, S., Sondermann, W., Livingstone, E., Sucker, A., Paschen, A., Zhao, F., Placke, J. M., Klose, J. M., Fendler, W. P., Thommen, D. S., Helfrich, I., Schadendorf, D., & Roesch, A. (2023). Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nature Cancer. https://doi.org/10.1038/s43018-023-00610-2

Source records

crossref · retrieved 2026-09-26T13:58:35.381Z